Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDOCAN-1
ISRCTN13210908Phase 2Recruiting
- Sponsor
- University of Edinburgh
- Start
- Aug 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in endometriosis comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Feasibility of recruitment and retention. Started Aug 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
endometriosis
Beyond the preview
Go deeper on ISRCTN13210908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13210908.